135 related articles for article (PubMed ID: 36929616)
1. Lymph node metastasis-dependent molecular classification in papillary thyroid carcinoma defines aggressive metastatic outgrowth.
Seo DH; Lee SG; Lee HY; Jeong S; Park S; Lee J; Jo YS
Clin Transl Med; 2023 Mar; 13(3):e1211. PubMed ID: 36929616
[No Abstract] [Full Text] [Related]
2. Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis.
Song Y; Fu LJ; Li HT; Qiu XG
Sci Rep; 2019 Apr; 9(1):5800. PubMed ID: 30967566
[TBL] [Abstract][Full Text] [Related]
3. Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma.
Jin S; Bao W; Yang YT; Bai T; Bai Y
Sci Rep; 2018 Nov; 8(1):17355. PubMed ID: 30478394
[TBL] [Abstract][Full Text] [Related]
4. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis with ARMS PCR.
Zhang J; Yang Y; Zhao J; Shi L; Xu Y; Yu K; Guo C
Pathol Res Pract; 2019 Apr; 215(4):761-765. PubMed ID: 30819583
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastasis in the space between the right carotid artery and jugular vein in papillary thyroid carcinoma.
Chen J; Zhang D; Fang L; He G; Gao L
J Int Med Res; 2020 Apr; 48(4):300060520920036. PubMed ID: 32326781
[TBL] [Abstract][Full Text] [Related]
6. Letter to the Editor From Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-Associated Mortality Risk in Papillary Thyroid Cancer".
Boucai L; Tuttle RM
J Clin Endocrinol Metab; 2022 May; 107(6):e2638-e2639. PubMed ID: 35262726
[No Abstract] [Full Text] [Related]
7. Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation.
Odate T; Oishi N; Kawai M; Tahara I; Mochizuki K; Akaishi J; Ito K; Katoh R; Kondo T
Endocr Pathol; 2021 Sep; 32(3):347-356. PubMed ID: 33761111
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
9. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
[TBL] [Abstract][Full Text] [Related]
10. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features.
Cho U; Mete O; Kim MH; Bae JS; Jung CK
Mod Pathol; 2017 Jun; 30(6):810-825. PubMed ID: 28281551
[TBL] [Abstract][Full Text] [Related]
11. Correlation between US-FNAC with BRAF V600E Mutation Analysis and Central Neck Lymph Node Metastasis in cN0 Papillary Thyroid Cancer.
Li R; Hao J; Zhu Z; Qiao X; Wang L; Zhou Z
Biomed Res Int; 2021; 2021():9937742. PubMed ID: 34307677
[TBL] [Abstract][Full Text] [Related]
12. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
[No Abstract] [Full Text] [Related]
13. [Risk factors of central neck lymph node metastasis in cN0 papillary thyroid carcinoma].
Zhang AB; Liu LF; Lu C; Ma YY; Dong YB; Ge XY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1141-1145. PubMed ID: 29798345
[No Abstract] [Full Text] [Related]
14. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.
Kim J; Giuliano AE; Turner RR; Gaffney RE; Umetani N; Kitago M; Elashoff D; Hoon DS
Ann Surg; 2006 Nov; 244(5):799-804. PubMed ID: 17060774
[TBL] [Abstract][Full Text] [Related]
16. Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.
Kure S; Wada R; Naito Z
Med Mol Morphol; 2019 Dec; 52(4):181-186. PubMed ID: 30788603
[TBL] [Abstract][Full Text] [Related]
17. BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases.
Fakhruddin N; Jabbour M; Novy M; Tamim H; Bahmad H; Farhat F; Zaatari G; Aridi T; Kriegshauser G; Oberkanins C; Mahfouz R
Sci Rep; 2017 Jul; 7(1):4666. PubMed ID: 28680105
[TBL] [Abstract][Full Text] [Related]
18. BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.
Walts AE; Pao A; Sacks W; Bose S
Hum Pathol; 2014 May; 45(5):935-41. PubMed ID: 24746198
[TBL] [Abstract][Full Text] [Related]
19. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Recent advances in papillary thyroid carcinoma: Lymph node metastasis.
Carrillo JF; Volpi EM
Front Endocrinol (Lausanne); 2022; 13():1084034. PubMed ID: 36506079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
